BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4418174)

  • 1. Soluble membrane antigens of human malignant melanoma cells.
    Hollinshead AC; Herberman RB; Jaffurs WJ; Alpert LK; Minton JP; Harris JE
    Cancer; 1974 Oct; 34(4):1235-43. PubMed ID: 4418174
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed hypersensitivity skin reactions to antigens on human tumors.
    Herberman RB
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1469-73. PubMed ID: 4609389
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation and identification of soluble skin-reactive membrane antigens of malignant and normal human breast cells.
    Hollinshead AC; Jaffurs WT; Alpert LK; Harris JE; Herberman RB
    Cancer Res; 1974 Nov; 34(11):2961-8. PubMed ID: 4138143
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells.
    Hollinshead AC; Stewart TH; Herberman RB
    J Natl Cancer Inst; 1974 Feb; 52(2):327-38. PubMed ID: 4131424
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of tumor-specific and herpesvirus nonvirion antigens.
    Hollinshead A; Tarro G; Foster WA; Seigel LJ; Jaffurs W
    Cancer Res; 1974 May; 34(5):1122-5. PubMed ID: 4842911
    [No Abstract]   [Full Text] [Related]  

  • 6. Specificity of delayed cutaneous hypersensitivity reactions to extracts of human tumor cells.
    Weese JL; Herberman RB; Hollinshead AC; Cannon GB; Keels M; Kibrite A; Morales A; Char DH; Oldham RK
    J Natl Cancer Inst; 1978 Feb; 60(2):255-63. PubMed ID: 74413
    [No Abstract]   [Full Text] [Related]  

  • 7. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
    Kokoschka EM
    Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of soluble melanoma cell membrane antigens in metastatic cells of various organs and further studies of antigens present in primary melanoma.
    Hollinshead AC
    Cancer; 1975 Oct; 36(4):1282-8. PubMed ID: 51680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.
    Hellström I; Sjögren HO; Warner G; Hellström KE
    Int J Cancer; 1971 Mar; 7(2):226-37. PubMed ID: 5104167
    [No Abstract]   [Full Text] [Related]  

  • 10. Reactivity between herpesvirus type 2-related soluble cervical tumor cell membrane antigens and matched cancer and control sera.
    Hollinshead A; Lee OB; McKelway W; Melnick JL; Rawls WE
    Proc Soc Exp Biol Med; 1972 Nov; 141(2):688-93. PubMed ID: 4564620
    [No Abstract]   [Full Text] [Related]  

  • 11. Further studies on an immunoenzymatic assay for herpes simplex virus tumor-associated antigen.
    Tarro G; Flaminio G; Maturo S; Esposito C; Cocchiara R
    Clin Immunol Immunopathol; 1982 Oct; 25(1):126-32. PubMed ID: 6295672
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.
    Mavligit GM; Ambus U; Gutterman JU; Hersh EM; McBride CM
    Nat New Biol; 1973 Jun; 243(127):188-90. PubMed ID: 4514633
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification of soluble human melanoma-associated antigens.
    Roth JA; Slocum HK; Pellegrino MA; Holmes EC; Reisfeld RA
    Cancer Res; 1976 Jul; 36(7 PT 1):2360-4. PubMed ID: 776393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed cutaneous hypersensitivity reactions to melanoma antigen.
    Holmes EC; Roth JA; Morton DL
    Surgery; 1975 Aug; 78(2):160-4. PubMed ID: 1154259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
    Cummings FJ; Heppner GH; Stolbach L; Calabresi P
    Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of a new oncofoetal antigen associated with several types of human carcinomas.
    Fritsché R; Mach J
    Nature; 1975 Dec; 258(5537):734-7. PubMed ID: 1207757
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed cutaneous hypersensitivity reactions to extracts of breast cancer and melanoma tissue in cancer patients.
    Fossati G; Canevari S; Pierotti MA; Vezzoni P; Porta GD; Vaglini M
    J Natl Cancer Inst; 1979 Jun; 62(6):1381-5. PubMed ID: 286110
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and partial characterization of melanoma-associated antigens identified by autologous antibody.
    Vlock DR; Scalise D; Meglin N; Kirkwood JM; Ballou B
    J Clin Invest; 1988 Jun; 81(6):1746-51. PubMed ID: 3384949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for tumor-specific antigens in filtered tissue culture media from human cancer cells.
    Hickok DF; Miller L
    In Vitro; 1974; 10(3-4):157-66. PubMed ID: 4452557
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic testing as a guide to cancer management.
    Wanebo HJ
    Surg Clin North Am; 1979 Apr; 59(2):323-47. PubMed ID: 375447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.